Bexarotene and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bexarotene (bexarotene) and Cyclophosphamide (cyclophosphamide). Common drug interactions include malignant neoplasm progression among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Bexarotene and Cyclophosphamide. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Bexarotene?

Bexarotene has active ingredients of bexarotene. eHealthMe is studying from 616 Bexarotene users. Check the latest studies of Bexarotene.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

On Jul, 08, 2026

36 people who take Bexarotene and Cyclophosphamide together, and have interactions are studied.

Bexarotene and Cyclophosphamide drug interactions.

What are the common drug interactions of Bexarotene and Cyclophosphamide, by gender? *:

female:

Malignant neoplasm progression (cancer tumour came back)
Symptom masked
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug ineffective
Dyslipidaemia (abnormal amount of lipids)
Infection
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Pain
Abasia (inability to walk)

male:

Drug ineffective
Disease progression
Paraplegia (paralysis of the legs and lower body)
Pneumonia
Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
Sepsis (a severe blood infection that can lead to organ failure and death)
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
T-cell lymphoma (a blood cell cancer)
Death
Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Bexarotene and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Symptom masked
Drug ineffective
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Disease progression
Dyslipidaemia (abnormal amount of lipids)
Death
Hyperphagia (an abnormal appetite for food)
Hypertriglyceridaemia (excess of triglycerides in the blood)
Pain

40-49:

Disease progression
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Mycosis fungoides refractory (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin unmanageable)
Abasia (inability to walk)
Abscess (pus)
Bacteraemia (presence of bacteria in the blood)
Fatigue (feeling of tiredness)
H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)

50-59:

Drug ineffective
Mycosis fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin)
Infection
Sepsis (a severe blood infection that can lead to organ failure and death)
T-cell lymphoma (a blood cell cancer)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
Tuberculosis (a bacterial infection by mycobacterium tuberculosis)

60+:

Malignant neoplasm progression (cancer tumour came back)
Anaplastic large cell lymphoma t- and null-cell types (t-cell or null-cell cancer, a type of blood cancer)
Skin ulcer
Hyperglycaemia (high blood sugar)
Lymphoproliferative disorder (a medical condition in which the immune system makes too many white blood cells)
Papule
Paraplegia (paralysis of the legs and lower body)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin lesion

What are the existing conditions these people have? *

Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 12 people, 33.33%
Hepatitis B: 5 people, 13.89%
T-Cell Lymphoma (a blood cell cancer): 4 people, 11.11%
T-Cell Lymphoma Stage Iv (one or more organs beyond the lymph nodes are affected with cancer of lymph node): 3 people, 8.33%
Peripheral T-Cell Lymphoma Unspecified Stage Iv (peripheral t-cell cancer unspecified stage iv): 3 people, 8.33%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 5.56%
Hepatic Function Abnormal: 2 people, 5.56%
Anaplastic Large Cell Lymphoma T- And Null-Cell Types (t-cell or null-cell cancer, a type of blood cancer): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Bexarotene and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously